A comprehensive view of American Diabetes Association. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
DaVita and the American Diabetes Assn. expand multi-year collaboration to address diabetes and chronic kidney disease; DaVita puts an additional US$1.5M support into ADA's initiatives for at-risk individuals, particularly in communities of color
Published:
March 11, 2024
by DaVita Inc.
|
The American Diabetes Assn. announces more than US$4.8M in Pathway to Stop Diabetes grants
Published:
February 07, 2024
by American Diabetes Association
|
American Diabetes Assn. releases 2024 Standards of Care in Diabetes, updated guidelines include new class of obesity drugs, diabetes technology advancement, recommendations for new screening practices, and the use of teplizumab for managing diabetes
Published:
December 11, 2023
by American Diabetes Association
|
The American Diabetes Assn. and Genentech launch Eye Pledge to Fight Diabetes campaign to promote eye exams to prevent diabetes-related vision loss; diabetes-related eye disease affects around 8 million in US
Published:
October 30, 2023
by American Diabetes Association
|
American Diabetes Assn. presses Congress to act on rebate reform; association seeks an increase in transparency in prescription drug rebates and asks Congress to prevent pharmacy benefit manager practices from inflating the cost of prescription drugs
Published:
September 08, 2023
by American Diabetes Association
|
Ask us about our Health Care Sector market view